Cannabis Medicine (CMD)

The purpose of this course is to review potential adverse effects of cannabinoids that may be related to route of exposure/administration, drug-drug interactions, individual physiology, and other factors that require full exploration if students are eventually to advise patients on how best to use available cannabinoid therapy safely. The course will take a systems-based approach, characterizing effects on function in the areas sensorimotor, cognition and affect, hepatic and cardiovascular, to name a few.

This course will review the evolving field and knowledge base of Cannabis medicine as it continues to elucidate through observation and scientific investigation the potential therapeutic efficacy of Cannabis or cannabinoids for nervous system diseases. This course will review the current knowledge of 1) basic pathology for nervous system diseases, 2) their current treatment, and 3) the plausible role cannabinoids and the endocannabinoid system may play in their symptomatology and treatment. The discussion will include primarily neurologic, psychiatric and behavioral conditions, as well as overlapping and blended diagnoses.

This course will review the evolving field and knowledge base of Cannabis medicine as it continues to elucidate through observation and scientific investigation the potential therapeutic efficacy of Cannabis or cannabinoids for somatic disorders. This course will review the current knowledge base of 1) basic pathology for select somatic diseases and disorders, 2) their current treatment, and 3) the plausible role cannabinoids and the endocannabinoid system may play in their symptomatology and treatment. The discussion will include gastrointestinal and hepatic, gynecologic, musculoskeletal, hematologic, and oncologic conditions, as well as overlapping and blended diagnoses.